EA
UTHR icon

Emerald Acquisition’s United Therapeutics UTHR Stock Holding History

Emerald Acquisition’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		$55.7M Buy
472,064
+24,862
+6% +$2.99M 0.11% 214
2016
Q2 		$47.4M Buy
+447,202
New +$49.9M 0.08% 285

Other funds holding UTHR

SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
AL
AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Emerald Acquisition's UTHR Position: Q3 2016 in Review

Emerald Acquisition increased its United Therapeutics (UTHR) stake by 5.6% in Q3 2016, buying an estimated $2.99M and bringing the position to 472,064 shares worth $55.7M. The position accounts for 0.11% of the portfolio, ranked #214.

Emerald Acquisition first reported a position in UTHR in Q2 2016 and has held it in 2 quarters since. 394 funds tracked by Wall St. Rank hold UTHR as of Q3 2016.

  • Emerald Acquisition held 472,064 shares of United Therapeutics worth $55.7M as of Q3 2016.
  • Emerald Acquisition bought 24,862 United Therapeutics shares in Q3 2016, an estimated $2.99M.
  • United Therapeutics made up 0.11% of Emerald Acquisition's portfolio in Q3 2016, its #214 holding.
  • Emerald Acquisition first reported a position in United Therapeutics in Q2 2016 and has held it in 2 quarters since.
  • 394 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2016.

Based on Emerald Acquisition's 13F filing for Q3 2016, filed 9 Nov 2016.